Status:
UNKNOWN
Contra-attitudinal Versus Mindfulness Treatment in Anorexia Nervosa Controlled Trial
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Anorexia Nervosa
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This study propose to compare the effectiveness of two care programs, the CAT and cognitive therapy based on mindfulness (Mindfulness-Based Cognitive Therapy, MBCT) compared to the usual care ("Treate...
Detailed Description
The patients will be recruited from the active files of the four centers participating in the study. In order to avoid the disappointment bias, they will be randomized into three groups, according to ...
Eligibility Criteria
Inclusion
- Anorexia nervosa as defined by the DSM-5 (anorexia nervosa of pure restrictive type F50.01 or purgative type F50.02),
- 14 \< BMI \< 18.5 (outpatient management possible)
- Affiliation to a social security scheme or beneficiary of such a scheme
- Signed informed consent
Exclusion
- other group support of their TCA
- regular psychological follow-up for a main psychiatric disorder other than TCA
- mental retardation or psychiatric pathology other than TCA or severe somatic not allowing efficient participation in the therapeutic program and interviews
- presence, at the time of the study, of a chronic condition that typically affects weight (digestive disease such as celiac disease, Crohn's disease; malignant tumor pathology; endocrine pathology such as hypo/hyperthyroidism, hyper/ hypocortisolism, pituitary or hypothalamic tumor, etc.).
- refusal to participate in the study
- pregnant, lactating women
- period of exclusion from another study,
- administrative or judicial supervision
- subject cannot be contacted in case of emergency
- Ancillary study: Volunteers will be excluded from the control group:
- having a significant biological abnormality
- a history of TCA or pathology likely to impact protein metabolism,
- pregnancy or breastfeeding at the time of the blood sample,
- under guardianship, deprivation of liberty, administrative or judicial supervision and exclusion from another study.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2024
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT05362981
Start Date
April 1 2022
End Date
June 1 2024
Last Update
June 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Julien Colombat
Grenoble, France